Event Details

This document is page 120 of a December 2017 Cannabis Investment Report by Ackrell Capital. It analyzes the stock price performance and capital raising activities of cannabis-related companies in the U.S., Canada, and Australia, noting resilience despite U.S. political changes (Trump/Sessions) and growth driven by Canadian legislation and strategic investments. The document bears a 'HOUSE_OVERSIGHT' stamp, but contains no direct mentions of Jeffrey Epstein or his known associates on this specific page.

This document is page 128 of a December 2017 Cannabis Investment Report by Ackrell Capital. It features a line graph tracking Canadian Cannabis Stock Price Performance against various indices from September 2016 to November 2017, highlighting market events such as the PM's legalization announcement and Constellation Brands' investment in Canopy Growth. The page bears the Bates stamp HOUSE_OVERSIGHT_024764, indicating it is part of a larger production of documents, likely related to congressional oversight, though no specific connection to Jeffrey Epstein or his associates is visible in the text of this specific page.